Comparative analysis of anticancer properties of So and selenium nanoparticles in a thioacetamide-induced HCC model

This publication has 58 references indexed in Scilit:

• Selenium nanoparticles and quercetin suppress thioacetamide‐induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement
  Journal of Biochemical and Molecular Toxicology, 2022
• OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis
  Journal of Medical Virology, 2020
• Insight into the role of TRAIL in liver diseases
  Biomedicine & Pharmacotherapy, 2019
• A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy
  Acta Biomaterialia, 2018
• Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
  Hepatology, 2016
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
  International Journal of Cancer, 2014
• Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
  Cancer Letters, 2013
• EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
  International Journal of Cancer, 2012
• Inflammation and Cancer: IL-6 and STAT3 Complete the Link
  Cancer Cell, 2009
• Immunohistochemical detection of transforming growth factor-β1 in fibrotic liver diseases
  Hepatology, 1991